Literature DB >> 19615364

Focus on molecules: maspin.

Malathi Narayan1, Sally Twining.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19615364      PMCID： PMC2789168          DOI： 10.1016/j.exer.2009.07.003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  4 in total

1.  The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix.

Authors:  Ruby H P Law; James A Irving; Ashley M Buckle; Katya Ruzyla; Marguerite Buzza; Tanya A Bashtannyk-Puhalovich; Travis C Beddoe; Kim Nguyen; D Margaret Worrall; Stephen P Bottomley; Phillip I Bird; Jamie Rossjohn; James C Whisstock
Journal:  J Biol Chem       Date:  2005-03-10       Impact factor: 5.157

2.  Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule.

Authors:  Chatri Ngamkitidechakul; Debra J Warejcka; Janice M Burke; William J O'Brien; Sally S Twining
Journal:  J Biol Chem       Date:  2003-06-10       Impact factor: 5.157

3.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

4.  Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

Authors:  Mark A Horswill; Malathi Narayan; Debra J Warejcka; Lisa A Cirillo; Sally S Twining
Journal:  Exp Eye Res       Date:  2008-01-12       Impact factor: 3.467
  4 in total
  5 in total

1.  Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.

Authors:  Debra J Warejcka; Malathi Narayan; Sally S Twining
Journal:  Exp Eye Res       Date:  2011-07-27       Impact factor: 3.467

2.  Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.

Authors:  Thomas M Bodenstine; Richard E B Seftor; Elisabeth A Seftor; Zhila Khalkhali-Ellis; Nicole A Samii; J Cesar Monarrez; Grace S Chandler; Philip A Pemberton; Mary J C Hendrix
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

3.  Effect of epigenetic modification of maspin on extravillous trophoblastic function.

Authors:  Xinwei Shi; Yuanyuan Wu; Haiyi Liu; Xun Gong; Hui Du; Yuqi Li; Jun Zhao; Ping Chen; Guiju Tang; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

4.  Maspin is a deoxycholate-inducible, anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis.

Authors:  Claire M Payne; Hana Holubec; Cheray Crowley-Skillicorn; Huy Nguyen; Harris Bernstein; George Wilcox; Carol Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-10-03

5.  Tumor Suppressive Maspin-Sensitized Prostate Cancer to Drug Treatment Through Negative Regulating Androgen Receptor Expression.

Authors:  Sijie Tang; Xueqi Lian; Jiajia Jiang; Huiying Cheng; Jiaqian Guo; Can Huang; Hong Meng; Xiaohua Li
Journal:  Front Cell Dev Biol       Date:  2020-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.